Evaluation of The Stanford Tobacco Prevention Toolkit

Sponsor
Stanford University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04467034
Collaborator
Tobacco Related Disease Research Program (Other)
0
1
2
7.5
0

Study Details

Study Description

Brief Summary

The Stanford Tobacco Prevention Toolkit is a free online curriculum developed for use by educators and health professionals in providing tobacco-specific prevention education to middle and high school students. The aims of this study are to determine: (1) whether the Curriculum is effective in changing middle and high school students' resistance to using tobacco as well as knowledge of, attitudes towards, and intentions to use different tobacco products; and (2) whether the Curriculum is effective in changing middle and high school students' actual use of tobacco in the short-term.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Stanford Tobacco Prevention Toolkit curriculum
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Randomized Controlled Trial to Evaluate The Stanford Tobacco Prevention Toolkit
Anticipated Study Start Date :
Oct 15, 2021
Anticipated Primary Completion Date :
Apr 30, 2022
Anticipated Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Receives Stanford tobacco education curriculum

Stanford Tobacco Prevention Toolkit is administered.

Behavioral: Stanford Tobacco Prevention Toolkit curriculum
Stanford Toolkit curriculum delivered as a 5-session course in a school classroom setting.

No Intervention: Does not receive Stanford tobacco education curriculum

Receives another curriculum or no tobacco education.

Outcome Measures

Primary Outcome Measures

  1. Change in resistance to use of tobacco products scaled score as measured by investigator-originated survey [Change from baseline to follow-up at approximately 40 weeks post-baseline]

    This survey measures change in resistance to use of tobacco products with questions related to the participant's intention to use tobacco.

Secondary Outcome Measures

  1. Change in skills for refusal of tobacco products scaled score as measured by investigator-originated survey [Change from baseline to follow-up at approximately 40 weeks post-baseline]

    This survey measures change in skills to refuse tobacco use with questions related to the participant's susceptibility to tobacco use, self-efficacy and self-confidence.

  2. Change in knowledge of tobacco products scaled score as measured by investigator-originated survey [Change from baseline to follow-up at approximately 40 weeks post-baseline]

    This survey measures knowledge of tobacco products with questions related to the participant's knowledge of ingredients, of nicotine levels, of potential health outcomes.

  3. This survey measures use of tobacco products with questions related to the participant's ever tobacco use, past 30-day tobacco use, and past 7-day tobacco use. [Change from baseline to follow-up at approximately 40 weeks post-baseline]

    Investigator-originated survey survey measures (questions) assess ever tobacco use, past 30-day tobacco use, past 7-day tobacco use This outcome measure assesses tobacco products use.

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 20 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Middle school and high school students
Exclusion Criteria:
  • Non English-speakers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Palo Alto California United States 94304

Sponsors and Collaborators

  • Stanford University
  • Tobacco Related Disease Research Program

Investigators

  • Principal Investigator: Bonnie L Halpern-Felsher, Stanford School of Medicine, Department of Pediatrics
  • Principal Investigator: Michael Baiocchi, Stanford School of Medicine, Department of Epidemiology and Population Health

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Bonnie Halpern-Felsher, Professor of Pediatrics, Stanford University
ClinicalTrials.gov Identifier:
NCT04467034
Other Study ID Numbers:
  • 54817
First Posted:
Jul 10, 2020
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bonnie Halpern-Felsher, Professor of Pediatrics, Stanford University

Study Results

No Results Posted as of Aug 23, 2022